NP49425 Generic and Biosimilar Transition Medicines

  • The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

F14: Notice for changes or additional information

Notice identifier: 2025/S 000-054079

Procurement identifier (OCID): ocds-h6vhtk-0581ea (view related notices)

Published 4 September 2025, 5:01pm



Section one: Contracting authority/entity

one.1) Name and addresses

The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

1 South Gyle Crescent

Edinburgh

EH12 9EB

Contact

Cameron Wright

Email

cameron.wright@nhs.scot

Telephone

+44 7870831908

Country

United Kingdom

NUTS code

UKM - Scotland

Internet address(es)

Main address

http://www.nss.nhs.scot/browse/procurement-and-logistics

Buyer's address

https://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA11883


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

NP49425 Generic and Biosimilar Transition Medicines

two.1.2) Main CPV code

  • 33600000 - Pharmaceutical products

two.1.3) Type of contract

Supplies

two.1.4) Short description

Supply of generic and biosimilar transition medicines to NHS Scotland.


Section six. Complementary information

six.6) Original notice reference

Notice number: 2025/S 000-050443


Section seven. Changes

seven.1) Information to be changed or added

seven.1.2) Text to be corrected in the original notice

Section number

IV.2.2

Place of text to be modified

Time limit

Instead of
Date

22 September 2025

Local time

12:00pm

Read
Date

24 September 2025

Local time

12:00pm

Section number

IV.2.7

Place of text to be modified

Conditions for opening of tenders

Instead of
Date

22 September 2025

Local time

12:00pm

Read
Date

24 September 2025

Local time

12:00pm

Section number

II.2.7

Lot No

7

Place of text to be modified

Duration Start

Instead of
Date

1 April 2026

Read
Date

1 May 2026

seven.2) Other additional information

1) Invitation to Tender published later than expected. Adjustment to deadline to meet minimum timescale requirement.

2) Lot 7 start date changed to avoid originator marketing exclusivity infringement.